The Osteogenesis Imperfecta Type V Mutant BRIL/IFITM5 Promotes Transcriptional Activation of MEF2, NFATc, and NR4A in Osteoblasts

• Published in: International journal of molecular sciences 2022-02, Vol.23 (4), p.2148
• Main Authors: Maranda, Vincent, Gaumond, Marie-Hélène, Moffatt, Pierre
• Format: Article
• Language: English
• Subjects: 3T3 Cells; Animals; Biomedical materials; Bones; BRIL; Calcineurin; Calcineurin - genetics; Calcium - metabolism; Calcium ions; Cell Line; Density; Fractures; Gene expression; Genes; Genetic aspects; Genetic transcription; HEK293 Cells; Homeostasis; Humans; IFITM5; Immunomodulation; Immunoprecipitation; Membrane Proteins - genetics; Mice; Mineralization; Mutants; Mutation; Mutation - genetics; Myocyte enhancer factor 2; NFATC; NFATC Transcription Factors - genetics; osteoblast; Osteoblasts; Osteoblasts - metabolism; Osteogenesis; Osteogenesis imperfecta; Osteogenesis Imperfecta - genetics; Osteogenesis Imperfecta - metabolism; osteogenesis imperfecta type V; Physiology; Signal transduction; Signal Transduction - genetics; signaling; Stimulators; Tacrolimus; Transcription activation; Transcription factors; Transcription Factors - genetics; Transcriptional Activation - genetics; Transfection
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms23042148

BRIL (bone restricted ifitm-like; also known as IFITM5) is a transmembrane protein expressed in osteoblasts. Although its role in skeletal development and homeostasis is unknown, mutations in BRIL result in rare dominant forms of osteogenesis imperfecta. The pathogenic mechanism has been proposed to be a gain-of or neomorphic function. To understand the function of BRIL and its OI type V mutant (MALEP BRIL) and whether they could activate signaling pathways in osteoblasts, we performed a luciferase reporter assay screen based on the activity of 26 transcription factors. When overexpressed in MC3T3-E1 and MLO-A5 cells, the MALEP BRIL activated the reporters dependent on MEF2, NFATc, and NR4A significantly more. Additional co-transfection experiments with MEF2C and NFATc1 and a number of their modulators (HDAC4, calcineurin, RCAN, FK506) confirmed the additive or synergistic activation of the pathways by MALEP, and suggested a coordinated regulation involving calcineurin. Endogenous levels of members, as well as , were upregulated by MALEP BRIL. Y2H and co-immunoprecipitation indicated that BRIL interacted with CAML, but its contribution as the most upstream stimulator of the Ca -calcineurin-MEF2/NFATc cascade was not confirmed convincingly. Altogether the data presented provide the first ever readout to monitor for BRIL activity and suggest a potential gain-of-function causative effect for MALEP BRIL in OI type V, leading to perturbed signaling events and gene expression.